Get started
Author

Chee Goh

An integrated lifestyle intervention for mitigation of adverse effects associated with androgen deprivation therapy for prostate cancer (STAMINA): a multicentre, randomised trial
2026 · Liam Bourke, Derek J Rosario, et al. · The Lancet Oncology · 1
Preliminary evaluation of ProSpare®, a rectal obturator for prostate bed radiotherapy within the randomised multicentre POPS trial (NCT02978014)
2026 · Sarah Stewart, Karen Thomas, et al. · Frontiers in Oncology
PDF
Evaluating the use of ProSpare®, a rectal obturator in prostate bed radiotherapy: acute toxicity and dosimetric impact from the randomised, multi-centre phase II trial POPS (NCT02978014)
2026 · Sarah Stewart, Helen McNair, et al. · Clinical Oncology
The LDR BURST trial: a randomised controlled trial comparing the side effects of low-dose-rate brachytherapy against ultra-hypofractionated radiotherapy using spacer gel treatment in men with Cambridge Prognostic Groups 1–3 prostate cancer
2026 · William Hayhurst, Santiago Uribe-Lewis, et al. · BMJ Open
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial
2019 · Helena M. Earl, Louise Hiller, et al. · Newcastle University ePrints (Newcastle Univesity)
Works count: 5
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type